Tuyen Nguyen

eat, sleep, science

[Society of Surgical Oncology @SocSurgOnc]

#SSO2024 John Wayne Clinical Research Lecture

Phenomenal talk by @kandymarsy. "Targeting the Cell Cycle Machinery in Cancer- From Bench to the Clinic and Back”

Epitome of impactful translational research that is changing standard of care in treatment of sarcoma & breast cancer.

[George Molina @realgmolina]

#SSO2024 I really enjoyed the talk by @kandymarsy

Especially how she highlighted researchers/mentees who have led the work under her leadership and guidance.

[Khandan Keyomarsi @kandymarsy]

@realgmolina It was an honor to present our recent findings at the #SSO2024 highlighting the work from @ndttuyen and @junay_14 @MDAndersonNews @KellyKhunt

[Khandan Keyomarsi @kandymarsy]

After a very productive day presenting 2 studies at #AACR24 which attracted a lot of interest on the @BlueprintMeds CDK2 inhibitor, we got together with the KeyHunt lab alumni for some Sushi. @lindseyluo419 @junay_14 @ndttuyen @KellyKhunt

[Khandan Keyomarsi @kandymarsy]

Thrilled to see how our pre-clinical basic science work in the lab is being translated into promising new clinical trials with CDK2 inhibitors. Possible through collaborative efforts with Timothy Yap, Debu Tripathy, @KellyKhunt, Linjie Luo, and @ndttuyen. @MDAndersonNews

[Cancer Research @CR_AACR]

In this issue, @ndttuyen et al. identify a sequential therapeutic strategy targeting Rb then perturbing DNA synthesis that synergistically suppresses Rb-positive sarcomas and report an approach to noninvasively monitor response.
https://t.co/2Qp4NN81C3
@kandymarsy @KellyKhunt

[Tuyen Nguyen @ndttuyen]

This work wrapped up my amazing journey at @MDAnderson Cancer Center where I challenged my disciplinary boundaries and sought to go above and beyond. It was an amazing experience for me, a trained chemist, to work in the biological world and think like a translational scientist.

[Tuyen Nguyen @ndttuyen]

There is no better way of celebrating the new year than having my first author manuscript accepted for publication on @CR_AACR.
Thank you, Drs. @kandymarsy and @KellyKhunt, for giving me this incredible opportunity/training.

[Khandan Keyomarsi @kandymarsy]

Our study on the sequential targeting of retinoblastoma and DNA synthesis pathways as a therapeutic strategy for sarcomas that can be monitored in real time is officially out in @CR_AACR. @MDAndersonNews,@KellyKhunt, @ndttuyen . https://t.co/R8V5WOElyq

[Tuyen Nguyen @ndttuyen]

I can’t believe that I ran into Dr. Thu Annelise Nguyen from #TexasTech at #AACR22. It has been so long since I moved to Houston.
#AACR is such a wonderful occasion to re-connect with people.

[Matthew Herper @matthewherper]

Natural killer cells, primed with an antibody, induce remissions in patients with advanced lymphoma

By @adamfeuerstein #AACR22.

https://t.co/VtfzlvNAC9

[Khandan Keyomarsi @kandymarsy]

KeyHunt lab enjoying dinner @aacr22 with @SofiaMast1 and @KellyKhunt and @junay_14 and @ndttuyen and Hannah Wingate and Kara Lewis

[Tuyen Nguyen @ndttuyen]

@MDAndersonNews @SofiaMast1 @KellyKhunt @kandymarsy I am so proud of my lab bestie ♥️♥️♥️

[UT MD Anderson @UTMDAnderson]

Dr. Sofia Mastoraki shares a novel prognostic tool that may help identify patients with early-stage ER positive/HER2 negative breast cancer that will benefit from long-term endocrine therapy: https://t.co/9hZlofDXuX @SofiaMast1 @KellyKhunt @kandymarsy #AACR22 #EndCancer

[Nicole M. Kettner, PhD @kettnernm]

Excited to be at #AACR22 with first-timers @junay_14 and @ndttuyen